Cargando…

Serum levels of anti-Müllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study

As a specific predictor of ovarian reserve, serum anti-Müllerian hormone (AMH) has become an area of intense research interest in the field of assisted reproductive technology. We assessed the relationship between AMH levels and pregnancy outcomes in Chinese patients and investigate the influencing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Yanru, Wang, Lu, Li, Yian, Ai, Jiajia, Tian, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902445/ https://www.ncbi.nlm.nih.gov/pubmed/36746984 http://dx.doi.org/10.1038/s41598-023-28724-8

Ejemplares similares

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study
por: Drakopoulos, Panagiotis, et al.
Publicado: (2019)

Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
por: Jain, Shikha, et al.
Publicado: (2016)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
por: Chwalisz, Kristof
Publicado: (2023)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
por: Asakawa, Jumpei, et al.
Publicado: (2018)

Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium
por: Chen, Qian, et al.
Publicado: (2019)

Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study
por: Pan, Wei, et al.
Publicado: (2019)

Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?
por: Rzewuska, Anna Maria, et al.
Publicado: (2023)

Anti-Mullerian-hormone levels during pregnancy and postpartum
por: Köninger, Angela, et al.
Publicado: (2013)

Early gonadotropin-releasing hormone antagonist start improves follicular synchronization and pregnancy outcome as compared to the conventional antagonist protocol
por: Park, Chan Woo, et al.
Publicado: (2014)

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
por: Zhao, Shen, et al.
Publicado: (2023)

A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
por: Hoseini, Fatemeh Sadat, et al.
Publicado: (2014)

Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Has the Same Effect as Gonadotropin-Releasing Hormone Agonist Injections in Terms of Preparation for Transcervical Resection Myomectomy
por: Ito, Mika, et al.
Publicado: (2022)

Clinical application of serum anti-Müllerian hormone in women
por: Oh, So Ra, et al.
Publicado: (2019)

Impact of Accessory Corpus Luteum Induced by Gonadotropin-Releasing Hormone or Human Chorionic Gonadotropin on Pregnancy Rates of Dairy Cattle following Embryo Transfer: A META-Analysis
por: Chen, Fang, et al.
Publicado: (2023)

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2017)

Serum anti-Müllerian hormone (AMH) concentration during pregnancy: a longitudinal study
por: McCredie, Sarah, et al.
Publicado: (2023)

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
por: Shebley, Mohamad, et al.
Publicado: (2019)

Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
por: Rabati, Behnaz Khani, et al.
Publicado: (2012)

Correlation of serum anti-Mullerian hormone with hormonal and environmental parameters in Brazilian climacteric women
por: Gouvea, Thiago Magalhães, et al.
Publicado: (2022)

Evaluation of pregnancy outcomes using medroxyprogesterone acetate versus gonadotropin-releasing hormone antagonist in ovarian stimulation: A retrospective cohort study
por: Singh, Ekika, et al.
Publicado: (2022)

Kisspeptin regulates gonadotropin-releasing hormone secretion in gonadotropin-releasing hormone/enhanced green fluorescent protein transgenic rats
por: Xue, Haogang, et al.
Publicado: (2013)

SUN-250 Effects of Anti-Mullerian Hormone on the Expression of Gonadotropin Subunits in Pituitary Gonadotroph Cell Models
por: Kanasaki, Haruhiko, et al.
Publicado: (2020)

Maternal serum anti-Müllerian hormone in Sudanese women with preeclampsia
por: Agabain, Eiman, et al.
Publicado: (2017)

Development of the gonadotropin‐releasing hormone system
por: Duittoz, Anne H., et al.
Publicado: (2022)

The impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels
por: Hwu, Yuh-Ming, et al.
Publicado: (2011)

Anti-Müllerian hormone serum level and other markers associated with pregnancy outcome in oocyte donation
por: Delesalle, Anne-Sophie, et al.
Publicado: (2016)

Apoptotic Death of Prostate Cancer Cells by a Gonadotropin-Releasing Hormone-II Antagonist
por: Park, Sumi, et al.
Publicado: (2014)

Small molecule piperazinyl-benzimidazole antagonists of the gonadotropin-releasing hormone (GnRH) receptor
por: Fjellaksel, Richard, et al.
Publicado: (2017)

The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome
por: Chappell, Neil, et al.
Publicado: (2017)

Progress in Clinical Research on Gonadotropin-Releasing Hormone Receptor Antagonists for the Treatment of Prostate Cancer
por: Liu, Yi-Fu, et al.
Publicado: (2021)

Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
por: Hager, Marlene, et al.
Publicado: (2022)

Clinical Utilities of Anti-Müllerian Hormone
por: Russell, Nicole, et al.
Publicado: (2022)

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
por: Trudeau, Vance L, et al.
Publicado: (2010)

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
por: Hosein Rashidi, Batool, et al.
Publicado: (2019)

Diminished Ovarian Reserve Predisposes to Premature Luteinizing Hormone Surges in Gonadotropin-Releasing Hormone Antagonist Cycles in In vitro Fertilization
por: Kochhar, Puneet Kaur, et al.
Publicado: (2020)

Anti-Müllerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis
por: Edelsztein, Nadia Y., et al.
Publicado: (2016)

Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer
por: Walentowicz, Pawel, et al.
Publicado: (2013)

A case of equine cryptorchidism with undetectable serum anti-Müllerian hormone
por: MURASE, Harutaka, et al.
Publicado: (2019)

Serum Anti-Mullerian Hormone and Estradiol Concentrations in Gilts and Their Age at Puberty
por: Am-in, Nutthee, et al.
Publicado: (2020)

Correlation between the Serum Luteinizing Hormone to Folliclestimulating Hormone Ratio and the Anti-Müllerian Hormone Levels in Normo-ovulatory Women
por: Lee, Jong Eun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_du76ggv6n40qk7qulkukqaltii